Page last updated: 2024-11-12

dermaseptin s

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dermaseptin: 34 amino acid residues given in first source; antimicrobial peptide of amphibian skin [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID16130489
CHEMBL ID525200
MeSH IDM0192860

Synonyms (12)

Synonym
nh2-ala-leu-trp-lys-thr-met-leu-lys-lys-leu-gly-thr-met-ala-leu-his-ala-gly-lys-ala-ala-leu-gly-ala-ala-ala-asp-thr-ile-ser-gln-gly-thr-gln-cooh
dermaseptin s
dermaseptin
l-glutamine, l-alanyl-l-leucyl-l-tryptophyl-l-lysyl-l-threonyl-l-methionyl-l-leucyl-l-lysyl-l-lysyl-l-leucylglycyl-l-threonyl-l-methionyl-l-alanyl-l-leucyl-l-histidyl-l-alanylglycyl-l-lysyl-l-alanyl-l-alanyl-l-leucylglycyl-l-alanyl-l-alanyl-l-alanyl-l-.al
dermaseptin i
CHEMBL525200
dermaseptin s1
dermaseptin ds 01
dermaseptin s3(1-16)
dermaseptin (h-l-ala-l-leu-l-trp-l-lys-l-thr-l-met-l-leu-l-lys-l-lys-l-leu-gly-l-thr-l-met-l-ala-l-leu-l-his-l-ala-gly-l-lys-l-ala-l-ala-l-leu-gly-l-ala-l-ala-l-ala-l-asp-l-thr-l-ile-l-ser-l-gln-gly-l-thr-l-gln-oh)
136033-70-0
mfcd00146655

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" However, while DS4 was toxic toward both the parasite and the host erythrocyte, DS3 was toxic only toward the intraerythrocytic parasite."( Selective cytotoxicity of dermaseptin S3 toward intraerythrocytic Plasmodium falciparum and the underlying molecular basis.
Cicéron, L; Ghosh, JK; Guillaud, P; Kustanovich, I; Mazier, D; Mor, A; Shai, Y; Shaool, D, 1997
)
0.6
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID364610Antileishmanial activity against Leishmania major MHOM/IL/67/JERICHO-2 assessed as protozoal viability after 24 hrs by dye exclusion method2008Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17
Synthesis and antimicrobial activity of dermaseptin S1 analogues.
AID364609Antileishmanial activity against Leishmania major MHOM/IL/67/JERICHO-2 after 24 hrs by dye exclusion method2008Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17
Synthesis and antimicrobial activity of dermaseptin S1 analogues.
AID364596Antibacterial activity against Staphylococcus aureus Cowan 1 NCTC 8530 after 24 hrs by microdilution serial twofold assay2008Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17
Synthesis and antimicrobial activity of dermaseptin S1 analogues.
AID364597Antibacterial activity against Escherichia coli HB101 after 24 hrs by microdilution serial twofold assay2008Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17
Synthesis and antimicrobial activity of dermaseptin S1 analogues.
AID364599Antibacterial activity against Escherichia coli HB101 after 3 hrs by microdilution serial twofold assay2008Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17
Synthesis and antimicrobial activity of dermaseptin S1 analogues.
AID364603Toxicity assessed as hemolytic activity in human red blood cells after 30 mins2008Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17
Synthesis and antimicrobial activity of dermaseptin S1 analogues.
AID364598Antibacterial activity against Staphylococcus aureus Cowan 1 NCTC 8530 after 3 hrs by microdilution serial twofold assay2008Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17
Synthesis and antimicrobial activity of dermaseptin S1 analogues.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (105)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's17 (16.19)18.2507
2000's48 (45.71)29.6817
2010's33 (31.43)24.3611
2020's7 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.04 (24.57)
Research Supply Index4.66 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews9 (8.57%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other96 (91.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]